Clinical Trial Update: The Study of Efficacy and Safety of REGPARA Drug in Dialysis Patients Have High Blood Levels of Parathyroid [Phase 4]

View source ↗

Summary

Phase 4 clinical trial of REGPARA (cinacalcet) in dialysis patients with secondary hyperparathyroidism has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperparathyroidism

Drugs mentioned

• REGPARA (cinacalcet)

Snippet

Sponsor: Chulalongkorn University | Conditions: Hyperparathyroidism, Secondary | Phase 4 | Status: COMPLETED